For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Science, Spoken · SpokenLayer
December 1, 20229m 1s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise.
Learn about your ad choices: dovetail.prx.org/ad-choices